Evidence map›Paper›PMID 31564440›Full record

ArticleCell metabolism2020

Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1.

Kristin L Granlund, Sui-Seng Tee, Hebert A Vargas, Serge K Lyashchenko, Ed Reznik, Samson Fine, Vincent Laudone, James A Eastham, Karim A Touijer, Victor E Reuter and 9 more

Abstract read
In one paragraph

Article in Cell metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Increasing Infusion Times of Hyperpolarized [1-Magnetic resonance in medicine · 2026
    Article
  8. Review
  9. Potential Clinical Applications of HyperpolarizedRecent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  10. RUNX1T1 drives stem-like small-cell neuroendocrine prostate cancer identity.Frontiers in cell and developmental biology · 2026
    Article
  11. HyperpolarizedImaging neuroscience (Cambridge, Mass.) · 2026
    Article
  12. Article
  13. Stable electron-irradiated [1-Science advances · 2025
    Article
  14. Consensus recommendations for hyperpolarized [1-Magnetic resonance in medicine · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Quo Vadis HyperpolarizedZeitschrift fur medizinische Physik · 2025
    Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Kristin L GranlundRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sui-Seng TeeRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hebert A VargasRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Serge K LyashchenkoRadiochemistry and Molecular Imaging Probes (RIMP) Core, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ed ReznikEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Samson FinePathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Vincent LaudoneSurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
James A EasthamSurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Karim A TouijerSurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Victor E ReuterPathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Mithat GonenEpidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ramon E SosaRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Duane NicholsonRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
YanWei W GuoRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Albert P ChenGE Healthcare, Toronto, ON, Canada.
James TroppBerkshire Magnetics, Berkeley, CA, USA.
Fraser RobbGE Healthcare, Aurora, OH, USA.
Hedvig HricakRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
Kayvan R KeshariRadiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: rahimikk@mskcc.org.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Reproducibility of Hyperpolarized Pyruvate Metabolic Imaging in Prostate CancerR01CA195476 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI HRICAK, HEDVIG, KESHARI, KAYVAN R · 2016 to 2018
$822k
Human Tissue Culture Bioreactor and Hyperpolarized MR for Biomarker DiscoveryR00EB014328 · NIBIB · SLOAN-KETTERING INST CAN RESEARCH · PI KESHARI, KAYVAN R · 2013 to 2015
$735k
GE Diamond DNP PolarizerS10OD016422 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI HRICAK, HEDVIG, KESHARI, KAYVAN R · 2014 to 2014
$600k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA195476NIBIB NIH HHS R00 EB014328NIH HHS S10 OD016422
6 · The paper itself

Abstract

Metabolic imaging using hyperpolarized magnetic resonance can increase the sensitivity of MRI, though its ability to inform on relevant changes to biochemistry in humans remains unclear. In this work, we image pyruvate metabolism in patients, assessing the reproducibility of delivery and conversion in the setting of primary prostate cancer. We show that the time to max of pyruvate does not vary significantly within patients undergoing two separate injections or across patients. Furthermore, we show that lactate increases with Gleason grade. RNA sequencing data demonstrate a significant increase in the predominant pyruvate uptake transporter, monocarboxylate transporter 1. Increased protein expression was also observed in regions of high lactate signal, implicating it as the driver of lactate signal in vivo. Targeted DNA sequencing for actionable mutations revealed the highest lactate occurred in patients with PTEN loss. This work identifies a potential link between actionable genomic alterations and metabolic information derived from hyperpolarized pyruvate MRI.

Indexed as

AgedCarbon IsotopesHumansKineticsLactic AcidMagnetic Resonance ImagingMaleMiddle AgedMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersNeoplasm GradingProstatic NeoplasmsPTEN PhosphohydrolasePyruvic AcidReproducibility of ResultsRNA-SeqCarbon IsotopesLactic AcidMonocarboxylate Transport Protein 1Monocarboxylic Acid TransportersPTEN PhosphohydrolasePTEN protein, humanPyruvic AcidSymportersglycolytic fluxhyperpolarized pyruvatein vivo kineticsmetabolic imaging

Identifiers

PMID31564440
PMCPMC6949382

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.